Suspension of trading
Sunho Biologics, Inc. Stock
Stocks
2898
KYG8572S1021
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.390 HKD | -.--% |
|
-.--% | -3.77% |
| Market Cap | 906M 1.05B 134M 118M 109M 100M 188M 12.89B 191M 1.3B 507M 6.34B 502M 492M 21.91B | P/E 2023 * |
-
| P/E 2024 | -5.67x |
|---|---|---|---|---|---|
| Enterprise Value | 490M 568M 72.38M 63.57M 59.12M 54.25M 102M 6.97B 104M 702M 274M 3.43B 272M 266M 11.85B | EV / Sales 2023 * |
-
| EV / Sales 2024 | 3,059x |
| Free-Float |
32.45% | Yield 2023 * |
-
| Yield 2024 | - |
| 6 months | -5.89% | ||
| Current year | -3.77% |
| Current year | 5.49 |  | 8 |
| 1 year | 5.49 | | 8.6 |
| 3 years | 3 | | 15.42 |
| 5 years | 3 | | 15.42 |
| 10 years | 3 | | 15.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Xiao Ling Jiang
CEO | Chief Executive Officer | 44 | 2026-01-22 |
Chun Qin Xu
DFI | Director of Finance/CFO | 47 | 2023-07-21 |
Dong Cheng Jiang
PRN | Corporate Officer/Principal | 43 | 2023-07-21 |
| Director | Title | Age | Since |
|---|---|---|---|
Lu Wen Shi
BRD | Director/Board Member | 62 | 2023-07-21 |
Lan Feng
BRD | Director/Board Member | 47 | 2023-07-21 |
Feng Zhang
CHM | Chairman | 53 | 2023-07-21 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | +1.43% | - | 124M | |
| +1.07% | -3.49% | -3.35% | +10.44% | 46.86B | |
| +0.25% | +1.65% | +399.22% | +634.87% | 40.23B | |
| -0.27% | +4.45% | +11.81% | +65.64% | 36.23B | |
| +0.35% | +0.87% | +4.46% | -10.16% | 34.72B | |
| +3.14% | +1.02% | +4.76% | +40.92% | 27.89B | |
| -0.73% | +11.84% | +34.39% | +134.36% | 16.79B | |
| +0.47% | -2.74% | - | - | 16.74B | |
| +0.42% | -5.52% | -3.43% | +9.03% | 13.12B | |
| -2.68% | -2.49% | -11.36% | -33.61% | 12.7B | |
| Average | +0.20% | +0.73% | +48.66% | +106.44% | 24.54B | |
| Weighted average by Cap. | +0.48% | +0.91% | +74.38% | +136.27% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 17.53M 20.31M 2.59M 2.27M 2.12M 1.94M 3.65M 249M 3.7M 25.12M 9.81M 123M 9.72M 9.51M 424M | 38K 44.01K 5.61K 4.93K 4.58K 4.21K 7.9K 540K 8.03K 54.43K 21.27K 266K 21.07K 20.61K 919K |
| Net income | -133M -154M -19.6M -17.21M -16.01M -14.69M -27.6M -1.89B -28.03M -190M -74.27M -928M -73.57M -71.99M -3.21B | -79.96M -92.62M -11.81M -10.37M -9.65M -8.85M -16.63M -1.14B -16.89M -115M -44.75M -559M -44.33M -43.38M -1.93B |
| Net Debt | -201M -233M -29.68M -26.07M -24.25M -22.25M -41.8M -2.86B -42.45M -288M -112M -1.41B -111M -109M -4.86B | -416M -482M -61.45M -53.97M -50.19M -46.06M -86.54M -5.92B -87.88M -596M -233M -2.91B -231M -226M -10.06B |
Employees
128
- Stock Market
- Stocks
- 2898 Stock
Select your edition
All financial news and data tailored to specific country editions
